You do not have permission to edit this page, for the following reason:
Welcome! You're creating or editing a startup page.
If you haven't, we suggest reading our general editing principles first. Also note our position on AI-generated content.
Fill out the form, then add the page content below.
None of the form's fields are strictly mandatory, so skip them if you are uncertain of the values.
We strongly suggest using the Visual Editor. To do this:
Before moving further, please read the following notes on the page template:
Page Content {{PAGENAME}} is a Singapore-based startup developing [[medical ai]] to provide clinical decision support for interpretations of pathology whole slide image scans. ==Technology== Qritive offers a suite of AI-powered diagnostic modules designed to support pathologists across a broad range of clinical applications—from cancer diagnosis and metastasis detection on Hematoxylin and Eosin stained whole-slide images to biomarker analysis on immunohistochemistry whole-slide images. Their modules are able to analyse entire whole-slide images within seconds<ref>{{Cite web |title=Other AI Modules |url=https://www.qritive.com/other-ai-modules |access-date=2025-12-26 |website=Qritive |language=en}}</ref>. Qritive has developed a comprehensive image management system to streamline pathology workflows from slide viewing and case management to AI-supported diagnosis and structured reporting<ref>{{Cite web |title=Pantheon ™ |url=https://www.qritive.com/pantheon |access-date=2025-12-26 |website=Qritive |language=en}}</ref>. ==Traction== The startup's diagnostic solution to support detection and grading of prostate cancer was given Class C In Vitro Diagnostic (IVD) Approval from Singapore’s Health Sciences Authority in August 2025<ref>{{Cite web |last=Qritive |date=2025-08-05 |title=QAi Prostate Grade Receives Class C IVD Approval from Singapore’s Health Sciences Authority |url=https://www.qritive.com/post/qai-prostate-grade-receives-class-c-ivd-approval-from-singapore-s-health-sciences-authority |access-date=2025-12-26 |website=Qritive |language=en}}</ref> and regulatory approval from Abu Dhabi's Department of Health in July 2025<ref>{{Cite web |last=Qritive |date=2025-07-28 |title=QAi Prostate Grade Receives Regulatory Approval from Abu Dhabi’s Department of Health |url=https://www.qritive.com/post/qai-prostate-grade-receives-regulatory-approval-from-abu-dhabi-s-department-of-health |access-date=2025-12-26 |website=Qritive |language=en}}</ref>. In August 2025, Qritive announced that their lymph node metastasis detection solution would be adopted by Dr Lal PathLabs, an Indian diagnostic provider<ref>{{Cite web |last=Qritive |date=2025-08-20 |title=Dr Lal PathLabs Selects Qritive’s AI-Powered Solution to Strengthen Cancer Diagnostics |url=https://www.qritive.com/post/dr-lal-pathlabs-selects-qritives-ai-powered-solution-to-strengthen-cancer-diagnostics |access-date=2025-12-26 |website=Qritive |language=en}}</ref>. In September 2024, the startup announced a collaboration with Roche, to integrate their solution into Roche's digital pathology platform<ref>{{Cite web |last=Qritive |date=2024-09-11 |title=Qritive Joins Forces with Roche to Redefine Global Cancer Diagnostics with AI |url=https://www.qritive.com/post/qritive-joins-forces-with-roche-to-redefine-global-cancer-diagnostics-with-ai |access-date=2025-12-26 |website=Qritive |language=en}}</ref>. ==Accolades== In July 2025, the startup was selected as an awardee at the Japan Smart Healthy Aging QuickFire Challenge, an initiative by Johnson & Johnson Innovation to support breakthrough healthcare solutions focused on increasing healthy life expectancy in Japan<ref>{{Cite web |last=Qritive |date=2025-06-30 |title=Qritive Recognized in Japan Smart Healthy Aging QuickFire Challenge |url=https://www.qritive.com/post/qritive-recognized-in-japan-smart-healthy-aging-quickfire-challenge |access-date=2025-12-26 |website=Qritive |language=en}}</ref>. ==Funding== Qritive raised a $7.5 million Series A round led by [[MassMutual Ventures]] in January 2023<ref>{{Cite web |date=2023-01-09 |title=Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets |url=https://apnews.com/press-release/ein-presswire-newsmatics/business-medical-technology-singapore-ein-presswire-newsmatics-boston-0a6efe37a84d2126137b725f5790f30e |access-date=2025-12-26 |website=AP News |language=en}}</ref>.{{Startup/Funding history}} == References == {{Reflist}}
Save page Show preview Cancel